-+ 0.00%
-+ 0.00%
-+ 0.00%

ADBiotech Raises Convertible Bond Issue to KRW 1.49 Billion in Corrected Filing

PUBT·11/20/2026 08:46:01
Diffusion vocale
ADBiotech Raises Convertible Bond Issue to KRW 1.49 Billion in Corrected Filing
  • ADBiotech corrected its convertible bond issuance to 1.49 billion won from 1 billion won in a November 20, 2026, filing.
  • The conversion price fell to 672 won per share from 1,000 won, raising potential new shares to 2,217,261 from 1,000,000.
  • Payment shifted to November 30, 2026, from November 20, 2026; maturity moved to November 30, 2029, from November 20, 2029.
  • Proceeds remain earmarked for acquiring securities in other companies.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADBiotech Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261120000576), on November 20, 2026, and is solely responsible for the information contained therein.